Physician profile
Ryan C Maher
NPI 1467596924
$1,013.79
in general payments reported to CMS, 2019-2025
10 companies · $36.97 in 2025
The $36.97 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $366 · 2021: $178 · 2022: $116 · 2023: $34.67 · 2024: $175 · 2025: $36.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235 · Entertainment: $11.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.13 |
| Entertainment | $11.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $579.56 | 2020-2024 | Invisalign |
| Dentsply Sirona INC | $113.49 | 2024 | Implant Dentistry |
| Biohorizons Implant Systems INC. | $83.32 | 2021 | |
| Straumann USA LLC | $75.00 | 2019 | |
| Keystone Dental INC. | $43.05 | 2019-2024 | |
| USA Angelalign Technology Corp | $38.83 | 2023-2025 | |
| Ultradent Products INC | $23.64 | 2023-2024 | Opalescence |
| Gc America INC. | $19.31 | 2025 | G-Premio Bond, G-Aenial |
| Acadia Pharmaceuticals INC | $18.80 | 2024 | Nuplazid |
| Ormco Corporation | $18.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.